Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011

Academic Emergency Medicine

Volumn 20, Issue 8, 2013, Pages 786-794

  Peters, Timothy R ^a   Suerken, Cynthia K ^a   Snively, Beverly M ^a   Winslow, James E ^a   Nadkarni, Milan D ^a   Kribbs, Scott B ^b   Poehling, Katherine A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FORSYTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; CHILD; CLINICAL PRACTICE; CONFERENCE PAPER; DEMOGRAPHY; EMERGENCY CARE; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEMALE; FEVER; HEALTH INSURANCE; HUMAN; INFANT; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NOSE SMEAR; PANDEMIC; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID INFLUENZA TEST; RAPID TEST; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEASON; THROAT CULTURE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NORTH CAROLINA; PANDEMICS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84882322875     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12175     Document Type: Conference Paper

References (64)

1. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F,. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007; 4: e247.
2. Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004-2009. Pediatrics. 2013; 131: 207-16.
3. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002; 185: 147-52.
4. Walsh EE, Falsey AR, Hennessey PA,. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999; 160: 791-5.
5. Drinka PJ, Gravenstein S, Krause P, et al. Non-influenza respiratory viruses may overlap and obscure influenza activity. J Am Geriatr Soc. 1999; 47: 1087-93.
6. Talbot HK, Falsey AR,. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010; 50: 747-51.
7. Louie JK, Hacker JK, Gonzales R, et al. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center clinic during the influenza season. Clin Infect Dis. 2005; 41: 822-8.
8. Lee TC, Taggart LR, Mater B, Katz K, McGeer A,. Predictors of pandemic influenza infection in adults presenting to two urban emergency departments, Toronto, 2009. CJEM. 2011; 13: 7-12.
9. Carrat F, Tachet A, Housset B, Valleron AJ, Rouzioux C,. Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France. Br J Gen Pract. 1997; 47: 217-20.
10. Stein J, Louie J, Flanders S, et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med. 2005; 46: 412-9.
11. Peltola V, Reunanen T, Ziegler T, Silvennoinen H, Heikkinen T,. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis. 2005; 41: 1198-200.
12. Hoeven AM, Scholing M, Wever PC, Fijnheer R, Hermans M, Schneeberger PM,. Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection. 2007; 35: 65-8.
13. Ebell MH, Afonso AM, Gonzales R, Stein J, Genton B, Senn N,. Development and validation of a clinical decision rule for the diagnosis of influenza. J Am Board Fam Med. 2012; 25: 55-62.
14. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW,. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003; 112: 363-7.
15. Noyola DE, Paredes AJ, Clark B, Demmler GJ,. Evaluation of a neuraminidase detection assay for the rapid detection of influenza A and B virus in children. Pediatr Dev Pathol. 2000; 3: 162-7.
16. Abanses JC, Dowd MD, Simon SD, Sharma V,. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care. 2006; 22: 145-9.
17. Sharma V, Dowd MD, Slaughter AJ, Simon SD,. Effect of rapid diagnosis of influenza virus type a on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med. 2002; 156: 41-3.
18. Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis. 2009; 48: e89-92.
19. Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics. 2007; 119: e6-11.
20. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M,. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012; 156: 500-11.
21. Hurt AC, Baas C, Deng YM, Roberts S, Kelso A, Barr IG,. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respir Viruses. 2009; 3: 171-6.
22. Faix DJ, Sherman SS, Waterman SH,. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 361: 728-9.
23. Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol. 2009; 45: 191-5.
24. Katz MA, Lamias MJ, Shay DK, Uyeki TM,. Use of rapid tests and antiviral medications for influenza among primary care providers in the United States. Influenza Other Respir Viruses. 2009; 3: 29-35.
25. Mueller MR, Smith PJ, Baumbach JP, et al. Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season. Ann Emerg Med. 2010; 55: 32-9.
26. Garg S, Chaves SS, Perez A, et al. Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic. Clin Infect Dis. 2012; 55: e18-21.
27. Monto AS, Moult AB, Sharp SJ,. Effect of zanamivir on duration and resolution of influenza symptoms. Clin Ther. 2000; 22: 1294-305.
28. Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med. 2000; 343: 1282-9.
29. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. 2000; 283: 1016-24.
30. Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999; 282: 1240-6.
31. Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A,. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 1999; 282: 31-5.
32. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis. 1999; 180: 254-61.
33. Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. 1997; 337: 874-80.
34. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007; 45: 1568-75.
35. Lovegrove MC, Shehab N, Hales CM, Poneleit K, Crane E, Budnitz DS,. Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic. Public Health Rep. 2011; 126: 312-7.
36. Yen HL, Hoffmann E, Taylor G, et al. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses. J Virol. 2006; 80: 8787-95.
37. Monto AS, Kimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006; 50: 2395-402.
38. Graitcer SB, Gubareva L, Kamimoto L, et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis. 2011; 17: 255-7.
39. Sleeman K, Sheu TG, Moore Z, et al. Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11. Emerg Infect Dis. 2011; 17: 2043-6.
40. Blitz SG, Cram P, Chernew ME, Monto AS, Fendrick AM,. Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. Am J Manag Care. 2002; 8: 221-7.
41. Schwarzinger M, Housset B, Carrat F,. Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis. Pharmacoeconomics. 2003; 21: 215-24.
42. Rothberg MB, Bellantonio S, Rose DN,. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med. 2003; 139: 321-9.
43. Rothberg MB, Fisher D, Kelly B, Rose DN,. Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy. Arch Pediatr Adolesc Med. 2005; 159: 1055-62.
44. Talbird SE, Brogan AJ, Winiarski AP, Sander B,. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. Am J Health Syst Pharm. 2009; 66: 469-80.
45. Lee BY, McGlone SM, Bailey RR, et al. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS One. 2010; 5: e11284.
46. Centers for Disease Control and Prevention. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 season. Available at: http://www.cdc.gov/H1N1flu/recommendations.htm. Accessed May 30, 2013.
47. U.S. Food and Drug Administration. Emergency Use of Tamiflu in Infants Less Than 1 Year of Age. Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm183870.htm. Accessed May 30, 2013.
48. Kniss K, Epperson S, Blanton L, et al. Update: influenza activity-United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2011; 60: 705-2.
49. Mustaquim D, Bishop A, Epperson S, et al. Update: influenza activity-United States, 2009-10 season. MMWR Morb Mortal Wkly Rep. 2010; 59: 901-8.
50. Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis. 2004; 189: 706-10.
51. Cho CH, Woo MK, Kim JY, et al. Evaluation of five rapid diagnostic kits for influenza A/B virus. J Virol Methods. 2013; 187: 51-6.
52. Richards S, Conover C, DiOrio M, et al. Evaluation of rapid influenza diagnostic tests for Influenza A (H3N2)v Virus and updated case count-United States, 2012. MMWR Morb Mortal Wkly Rep. 2012; 61: 619-21.
53. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009; 8: 1-52.
54. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010; 8: 1-62.
55. Falsey AR, McCann RM, Hall WJ, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995; 43: 30-6.
56. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB,. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000; 283: 499-505.
57. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR,. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49: 1373-9.
58. Baxter R,. Surveillance lessons from first-wave pandemic (H1N1) 2009, Northern California, USA. Emerg Infect Dis. 2010; 16: 504-6.
59. Keramarou M, Cottrell S, Evans MR, et al. Two waves of pandemic influenza A(H1N1) 2009 in Wales-the possible impact of media coverage on consultation rates, April-December 2009. Euro Surveill. 2011; 16: pii:19772.
60. Gao F, Loring C, Laviolette M, Bolton D, Daly ER, Bean C,. Detection of 2009 pandemic influenza A(H1N1) virus infection in different age groups by using rapid influenza diagnostic tests. Influenza Other Respir Viruses. 2012; 6: e30-4.
61. Rothberg MB, Bonner AB, Rajab MH, Kim HS, Stechenberg BW, Rose DN,. Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. Clin Infect Dis. 2006; 42: 95-9.
62. Williams WW, Lu PJ, Lindley MC, Kennedy ED, Singleton JA,. Influenza vaccination coverage among adults-national health interview survey, United States, 2008-09 influenza season. MMWR Surveill Summ. 2012; 61: 65-72.
63. Centers for Disease Control and Prevention. Influenza Antiviral Medications: A Summary for Clinicians. Available at: http://www.cdc.gov/flu/ professionals/antivirals/summary-clinicians.htm. Accessed May 30, 2013.
64. U.S.Food and Drug Administration. FDA Expands Tamiflu's Use to Treat Children Younger Than 1 Year. Available at: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm333205.htm. Accessed May 30, 2013.